Abstract:Background: Congenital heart disease (CHD) is the most common congenital anomaly. Up to 33% have an identifiable genetic etiology. Improved medical and surgical management of CHD has translated into longer life expectancy and a rapidly growing population of adults living with CHD. The adult CHD (ACHD) population did not have access during childhood to the genetic technologies available today and therefore have not had a robust genetic evaluation that is currently recommended for infants with CHD. Given this potential benefit; the aims of this study were to determine how ACHD cardiologists offer genetics services to patients and identify the indications that influence decision-making for genetics care. Methods: We performed a descriptive cross-sectional study of ACHD cardiologists. A study-developed questionnaire was distributed via emailed REDCap link. The recruitment email was sent to 104 potential respondents. The survey was open from 06/2022 to 01/2023. Results: Thirty-five cardiologists participated in the study (response rate of 34%). Most cardiologists identified as white (77%) and male (66%). Cardiologists were more likely to refer patients to genetics (91%) than to order testing themselves (57%). Of the testing ordered, chromosomal testing (55%) was ordered more than gene sequencing (14%). Most cardiologists would refer a patient with a conotruncal lesion (interrupted aortic arch) over other indications for a genetics evaluation. There were more reported barriers to ordering genetic testing (66%) compared to referring to genetics for a genetics evaluation (23%). Cardiologists were more confident recognizing features suggestive of a genetic syndrome than ordering the correct test ( p = 0.001). Regarding associations between clinical factors and current practices, more years in practice trended towards less referrals and testing. Evaluating a greater number of patients ( p = 0.11) and greater confidence recognizing syndromic features ( p = 0.12) and ordering the correct test ( p = 0.09) were all associated with ordering more testing. Conclusion: Testing for microdeletion syndromes is being offered and completed in the ACHD population, however testing for single-gene disorders associated with CHD is being under-utilized. Developing guidelines for genetic testing in adults with CHD could increase access to genetic services, impact medical management, reduce uncertainty regarding prognosis, and inform recurrence risk estimates.

Congenital blindness with ocular developmental anomalies, including retinal dysplasia, in Doberman Pinscher dogs.

Current approach to genetic testing and genetic evaluation referrals for adults with congenital heart disease

Genetic investigation and diagnosis in adults with congenital heart disease with or without structural or neurodevelopmental comorbidity: a retrospective chart review

Clinical Genetic and Genomic Testing in Congenital Heart Disease and Cardiomyopathy

Genomic testing and molecular diagnosis among infants with congenital heart disease in the neonatal intensive care unit

Progresses in Genetic Testing in Congenital Heart Disease

Genetic Contribution to Congenital Heart Disease (CHD)

Clinical Decision Analysis of Genetic Evaluation and Testing in 1013 Intensive Care Unit Infants with Congenital Heart Defects Supports Universal Genetic Testing

[Specification for Genetic Diagnosis of Congenital Heart Disease].

Results of comprehensive genetic testing in patients presenting to a multidisciplinary inherited heart disease clinic in India

[Research Progress on Genetic and Epigenetic Mechanisms in Congenital Heart Disease].

Genetic Architecture in Neonatal Intensive Care Unit Patients with Congenital Heart Defects: a Retrospective Study from the China Neonatal Genomes Project.

Genetics and etiology of congenital heart disease

Diagnostic Value of Chromosomal Microarray Analysis for Fetal Congenital Heart Defects with Different Cardiac Phenotypes and Extracardiac Abnormalities

Understanding the Genetic and Non-Genetic Interconnections in the Aetiology of Syndromic Congenital Heart Disease: An Updated Review: Part 2

Hereditary Hypertrophic Cardiomyopathy in Children and Young Adults—The Value of Reevaluating and Expanding Gene Panel Analyses

Dissecting thoracoabdominal aortic aneurysm associated with an isolated right-sided aortic arch.

Genetic Analysis Algorithm for the Study of Patients with Multiple Congenital Anomalies and Isolated Congenital Heart Disease

Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity

Clinical presentation, genetic etiology and outcome associated with fetal cardiomyopathy: comparison of two eras

Clinical profile of congenital heart diseases detected in a tertiary hospital in China: a retrospective analysis